| Dr Ivan Sarria, MD | |
|
4203 Hospital Rd, Coal Township, PA 17866-9668 | |
| (570) 648-4010 | |
| (570) 648-5706 |
| Full Name | Dr Ivan Sarria |
|---|---|
| Gender | Male |
| Speciality | Obstetrics/gynecology |
| Experience | 32 Years |
| Location | 4203 Hospital Rd, Coal Township, Pennsylvania |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1962650879 | NPI | - | NPPES |
| 1021977770001 | Medicaid | PA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | MD434674 (Pennsylvania) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Altura Centers For Health | 9830103449 | 22 |
News Archive
In this post in the Hill's "Congress Blog," Kaitlin Christenson, the coalition director of the Global Health Technologies Coalition; Jim Connolly, president and CEO of Aeras; and Mel Spigelman, president and CEO of the TB Alliance, respond to a recently released G-FINDER report that shows "overall global investment in the research and development (R&D) of new global health technologies has declined for the first time since 2007, when the tracking of such funding began."
Myogen has announced that the United States Food and Drug Administration has granted orphan drug designation to ambrisentan for the treatment of pulmonary arterial hypertension (PAH).
Cedars-Sinai investigators have for the first time identified a gas produced in gut that could improve the diagnosis and treatment of patients with two common intestinal illnesses-;small intestine bacterial overgrowth and irritable bowel syndrome.
New data on four Bristol-Myers Squibb Company (NYSE:BMY) compounds will be presented at the 60th annual meeting of the American Association for the Study of Liver Diseases (AASLD) in Boston from October 30 to November 3.
Groundbreaking research from the University of Alberta has identified the structure of the infectious prion protein, the cause of "mad cow disease" or BSE, chronic wasting disease in deer and elk and Creutzfeldt-Jakob disease in humans, which has long remained a mystery.
› Verified 8 days ago
| Entity Name | Family Healthcare Network |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1164517744 PECOS PAC ID: 6305756339 Enrollment ID: O20040123000681 |
News Archive
In this post in the Hill's "Congress Blog," Kaitlin Christenson, the coalition director of the Global Health Technologies Coalition; Jim Connolly, president and CEO of Aeras; and Mel Spigelman, president and CEO of the TB Alliance, respond to a recently released G-FINDER report that shows "overall global investment in the research and development (R&D) of new global health technologies has declined for the first time since 2007, when the tracking of such funding began."
Myogen has announced that the United States Food and Drug Administration has granted orphan drug designation to ambrisentan for the treatment of pulmonary arterial hypertension (PAH).
Cedars-Sinai investigators have for the first time identified a gas produced in gut that could improve the diagnosis and treatment of patients with two common intestinal illnesses-;small intestine bacterial overgrowth and irritable bowel syndrome.
New data on four Bristol-Myers Squibb Company (NYSE:BMY) compounds will be presented at the 60th annual meeting of the American Association for the Study of Liver Diseases (AASLD) in Boston from October 30 to November 3.
Groundbreaking research from the University of Alberta has identified the structure of the infectious prion protein, the cause of "mad cow disease" or BSE, chronic wasting disease in deer and elk and Creutzfeldt-Jakob disease in humans, which has long remained a mystery.
› Verified 8 days ago
| Entity Name | Altura Centers For Health |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1023011632 PECOS PAC ID: 9830103449 Enrollment ID: O20090115000094 |
News Archive
In this post in the Hill's "Congress Blog," Kaitlin Christenson, the coalition director of the Global Health Technologies Coalition; Jim Connolly, president and CEO of Aeras; and Mel Spigelman, president and CEO of the TB Alliance, respond to a recently released G-FINDER report that shows "overall global investment in the research and development (R&D) of new global health technologies has declined for the first time since 2007, when the tracking of such funding began."
Myogen has announced that the United States Food and Drug Administration has granted orphan drug designation to ambrisentan for the treatment of pulmonary arterial hypertension (PAH).
Cedars-Sinai investigators have for the first time identified a gas produced in gut that could improve the diagnosis and treatment of patients with two common intestinal illnesses-;small intestine bacterial overgrowth and irritable bowel syndrome.
New data on four Bristol-Myers Squibb Company (NYSE:BMY) compounds will be presented at the 60th annual meeting of the American Association for the Study of Liver Diseases (AASLD) in Boston from October 30 to November 3.
Groundbreaking research from the University of Alberta has identified the structure of the infectious prion protein, the cause of "mad cow disease" or BSE, chronic wasting disease in deer and elk and Creutzfeldt-Jakob disease in humans, which has long remained a mystery.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Ivan Sarria, MD 100 N Academy Ave, Credentials Dept, Danville, PA 17822-4903 Ph: (570) 271-6144 | Dr Ivan Sarria, MD 4203 Hospital Rd, Coal Township, PA 17866-9668 Ph: (570) 648-4010 |
News Archive
In this post in the Hill's "Congress Blog," Kaitlin Christenson, the coalition director of the Global Health Technologies Coalition; Jim Connolly, president and CEO of Aeras; and Mel Spigelman, president and CEO of the TB Alliance, respond to a recently released G-FINDER report that shows "overall global investment in the research and development (R&D) of new global health technologies has declined for the first time since 2007, when the tracking of such funding began."
Myogen has announced that the United States Food and Drug Administration has granted orphan drug designation to ambrisentan for the treatment of pulmonary arterial hypertension (PAH).
Cedars-Sinai investigators have for the first time identified a gas produced in gut that could improve the diagnosis and treatment of patients with two common intestinal illnesses-;small intestine bacterial overgrowth and irritable bowel syndrome.
New data on four Bristol-Myers Squibb Company (NYSE:BMY) compounds will be presented at the 60th annual meeting of the American Association for the Study of Liver Diseases (AASLD) in Boston from October 30 to November 3.
Groundbreaking research from the University of Alberta has identified the structure of the infectious prion protein, the cause of "mad cow disease" or BSE, chronic wasting disease in deer and elk and Creutzfeldt-Jakob disease in humans, which has long remained a mystery.
› Verified 8 days ago
Dr. Bridget D. Roots, M.D. Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 4203 Hospital Rd, Coal Township, PA 17866 Phone: 570-648-4010 Fax: 570-648-5076 |